CardIQ Suite vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CardIQ Suite

by GE HealthCare

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

These tools are adjacent in their focus on cardiology but serve different diagnostic purposes. CardIQ Suite specializes in post-processing cardiac CT scans for comprehensive cardiovascular disease diagnosis and treatment planning, including calcium scoring and CCTA review. Tempus ECG-AF, on the other hand, analyzes 12-lead ECGs to identify older patients at risk of developing atrial fibrillation, focusing on early detection of a specific arrhythmia.

Choose CardIQ Suite if…

Choose CardIQ Suite if your practice regularly performs cardiac CT scans and requires an integrated, automated solution for comprehensive cardiovascular disease diagnosis and treatment planning. This tool excels at automated calcium scoring, CCTA review, and detailed visualization of coronary vasculature, aiding in the assessment of coronary artery disease, heart structures, and stent/bypass follow-up.

View CardIQ Suite →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if you need an AI-powered solution to identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation/flutter within the next 12 months. This tool analyzes 12-lead ECG recordings to support earlier identification and follow-up, particularly for patients without a pre-existing AF diagnosis or pacemakers.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CardIQ Suite	Tempus ECG-AF
Pricing	Unknown	Contact vendor
Deployment	On-premise (integrated with CT systems)	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardIQ Suite

CardIQ Suite emphasizes an 'integrated workflow for seamless review' and 'automation and workflow efficiency,' suggesting a user-friendly design for complex cardiac CT post-processing. Tempus ECG-AF, while integrated into existing systems, does not have a dedicated user interface, which might make direct interaction and control less intuitive for some users.

Clinical Value

CardIQ Suite

CardIQ Suite offers comprehensive cardiac CT post-processing, including automated calcium scoring, CCTA review, plaque identification, and analysis of chamber mobility, directly aiding in diagnosis and treatment planning for various cardiovascular diseases. Tempus ECG-AF focuses on identifying patients at increased risk of developing AF within 12 months, which is valuable for early detection, but its scope is narrower and it is not intended as a sole diagnostic tool.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF has transparent pricing details with established CMS reimbursement (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90, effective January 1, 2025), offering clear financial value for healthcare facilities. CardIQ Suite's pricing is available only upon contact, making it difficult to assess its value proposition without direct inquiry.

Enterprise Readiness

Tie

Both tools demonstrate enterprise readiness through their deployment models and compliance. CardIQ Suite is deployed on-premise with GE Advantage Workstation and AW Server, indicating integration within existing GE infrastructure. Tempus ECG-AF is a software solution integrated into healthcare facility systems and is compatible with major ECG devices like those from GE Medical Systems and Philips Medical Systems. Both are HIPAA compliant and have FDA clearance.

Innovation

CardIQ Suite

CardIQ Suite leverages deep learning for automated calcium scoring, coronary artery labeling, and plaque identification, showcasing advanced AI application in cardiac imaging. While Tempus ECG-AF also uses an AI-based algorithm for ECG analysis, its innovation is focused on a specific predictive task rather than the multi-faceted diagnostic and post-processing capabilities of CardIQ Suite.

Support & Docs

CardIQ Suite

GE Healthcare, as the company behind CardIQ Suite, is a large, established medical technology provider known for extensive support and documentation for its products. While Tempus AI is a technology company leading in AI for precision medicine, specific details regarding the breadth and depth of support and documentation for Tempus ECG-AF are not as readily available in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CardIQ Suite	Tempus ECG-AF
Name	CardIQ Suite	Tempus ECG-AF
Company	GE Medical Systems SCS	Tempus AI, Inc.
Description	AI-powered cardiac CT post-processing application, offering automated calcium scoring and CCTA review for comprehensive cardiovascular disease diagnosis and treatment planning.	FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI
Specialties	Cardiology, Radiology	Cardiology, Geriatrics, Internal Medicine
Key Features	Deep Learning based automated Calcium Score and labeling of coronary artery territories; Integrated workflow for seamless review of calcium scoring and CCTA data; CCTA 2D Review with cine capability for motion studies and chamber mobility analysis; Double oblique tools for detailed visualization of coronary vasculature; Measurement tools for distance and Region of Interest (ROI) generation; Ability to assign calcifications to individual coronary artery branches; Ability to score and label calcifications found in the aorta and cardiac valves; Plaque ID tool for visualizing and quantifying plaque burden (CardIQ Xpress 2.0 Reveal)	AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; Results interpreted in conjunction with other diagnostic information and clinical history; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems; Trained on over 1.5 million ECGs from over 500,000 patients

Videos

Demos, reviews, and walkthroughs featuring CardIQ Suite and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

CardIQ Suite is an integrated suite of CT cardiac post-processing tools designed for automation and workflow efficiency, seamlessly reviewing calcium scoring and CCTA data. Tempus ECG-AF is designed to work with existing ECG platforms and EHRs, using integrations and patient clinical data to filter eligible patients and deliver customized notifications within established clinical workflows.

What are the key differences in clinical utility and the patient populations each tool serves?

CardIQ Suite focuses on automated calcium scoring and CCTA review for comprehensive cardiovascular disease diagnosis and treatment planning, evaluating calcified plaques in coronary arteries, heart valves, and the aorta. Tempus ECG-AF analyzes 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within 12 months, specifically for those without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.

What is the accuracy and sensitivity of each tool in its respective application?

CardIQ Suite demonstrates high consistency with over 90% concordance in CACS-DRS classification grouping, over 95% correct identification of coronary artery calcifications, and over 90% accurately labeled coronary artery territories. Tempus ECG-AF demonstrated a sensitivity of 31% for classifying patients who developed clinically recognized AF within one year and a specificity of 92% for classifying patients who did not, with a positive predictive value of 19%.

What is the typical learning curve for physicians and support staff to effectively use each tool?

CardIQ Suite offers an integrated workflow and automated features for CT post-processing, implying it's intended for specialists reviewing complex cardiac CT data, which may suggest a higher prerequisite skill level. Tempus ECG-AF is designed without a dedicated user interface, integrating with other medical systems, which could simplify the learning curve for end-users as it works within existing systems.

What kind of customer support and resources are available for each tool?

Tempus provides a customer service team available Monday through Friday, 7 am to 7 pm CST, and offers various resources including a policy center, document library, and media library. Information regarding specific customer support details for CardIQ Suite is not provided in the given data, though GE Healthcare generally offers support for its products.

What are the audit-trail features and data security measures beyond HIPAA for these tools?

Tempus employs a rigorous de-identification process exceeding HIPAA standards, using advanced techniques to remove or mask direct identifiers. They also utilize a defense-in-depth security strategy with high-level encryption for data in transit and at rest, strict access controls, and regular independent third-party audits. Specific audit-trail features and security measures beyond HIPAA for CardIQ Suite are not detailed in the provided information.

Are there customer references or multi-site rollout considerations available to understand real-world implementation?

Tempus ECG-AF has undergone multi-site validation across three geographically distinct clinical sites, with results published in Heart Rhythm, and Northwestern Medicine is noted as an institution integrating ECG-AF into its clinical workflows. Information regarding customer references or multi-site rollout considerations for CardIQ Suite is not available in the provided data.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring CardIQ Suite or Tempus ECG-AF

Backers

Who funded each tool's parent company.